
About Aastha Oncology Private Limited
Data last updated:
Aastha Oncology Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the oncology clinics and cancer treatment segment of the healthcare sector. It was incorporated on 16 July 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U85110GJ2007PTC051327. Its GSTIN is 24AAGCA5597F1ZK (Gujarat).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹50 Lakh. It is led by directors including Vijay Govinda Devanhalli and Rajendra Bhagwandas Toprani.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ahmedabad, Gujarat.
As per the financials filed for FY 2024, the company reported a revenue of ₹38.19 Cr, a growth of 17% compared to the previous year. For the same year it recorded a net profit of ₹2.81 Cr (net margin 7.4%) and EBITDA of ₹2.85 Cr (EBITDA margin 7.5%). Revenue has grown at a compounded annual rate (CAGR) of 29% over three years and 18% over five years.
The company is associated with 1 brand: Aastha Oncology Associates. The company has 4 deals on record (3 secondary share transfers, 1 funding round), with disclosed funding of ₹20 Lakh; the latest was in March 2019.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website aasthacancer.org.
Company details
Contact details
Aastha Oncology Private Limited's registered office is in Ahmedabad, Gujarat. Its website is aasthacancer.org. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressHcg Aastha Cancer Centre C/O. Hcg Medi Surge Hospitals Private Limited, Tp – 56 Fp – 82 Survey No – 138/2 Opp. Sola Bhagvat Vidhyapith, Ahmedabad, Gujarat, India – 380060
- IndustryHealthcare, Oncology Clinics & Cancer Treatment
To see the full contact details of Aastha Oncology Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Aastha Oncology operates one associated brand: Aastha Oncology Associates. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers cancer diagnosis, treatment, and surgical services in Ahmedabad India. | aasthacancer.org |
Financials of Aastha Oncology Private Limited
FY 2025 filings availableAastha Oncology Private Limited reported revenue of ₹38.19 Cr (up 17% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 18% over five years, including 17% growth in the latest year. EBITDA fell 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹38.19 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.85 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.81 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.5% | ||||
| Net Profit Margin | 7.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Aastha Oncology Private Limited, buy the company report.
Board of directors of Aastha Oncology Private Limited
Aastha Oncology has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vijay Govinda Devanhalli Also directs: HCG Medi-Surge Hospitals Private Limited | Director | 17 Jul 2007 | 19 Years 4 Months | Current |
| Rajendra Bhagwandas Toprani Also directs: HCG Medi-Surge Hospitals Private Limited | Director | 17 Jul 2007 | 19 Years 4 Months | Current |
| Jagdishbhai Manubhai Kothari | Director | 16 Jul 2007 | 19 Years 4 Months | Current |
| Kaustubhbhai Dhirajlal Patel | Director | 16 Jul 2007 | 19 Years 4 Months | Current |
Auditor
Aastha Oncology Private Limited is audited by R. S. PATEL & CO. for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R. S. PATEL & CO. | FY 2024 | 107758W |
Shareholding
The shareholding of Aastha Oncology Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Aastha Oncology Private Limited, buy the company report.
Deals & funding
Aastha Oncology Private Limited has 4 deals on record (3 secondary share transfers, 1 funding round), with disclosed funding of ₹20 Lakh; the latest was in March 2019.
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2019 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 4 individuals |
| Jan 2019 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 4 individuals |
| Sep 2016 | Funding round | ₹20 Lakh | Investors: an individual |
| Mar 2009 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Aastha Oncology Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aastha Oncology Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Aastha Oncology has 1 associated company. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.
GST
Aastha Oncology has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAGCA5597F1ZK | Gujarat | Active | 01 Nov 2022 |
To see the full GST registrations and return filing status of Aastha Oncology Private Limited, buy the company report.
Recent activity
Aastha Oncology Private Limited has 6 board changes on record since 2007: 4 appointments and 2 cessations. The latest: Rajendra Bhagwandas Toprani ceased to be Additional Director on 30 Sep 2008.
Frequently asked questions
Aastha Oncology is an active private limited company based in Ahmedabad, Gujarat, India. The company works in oncology clinics and cancer treatment, within the healthcare industry. It was incorporated on 16 July 2007 (19+ years old) and is registered under CIN U85110GJ2007PTC051327.
Aastha Oncology has 4 current directors:
- Vijay Govinda Devanhalli - Director
- Rajendra Bhagwandas Toprani - Director
- Jagdishbhai Manubhai Kothari - Director
- Kaustubhbhai Dhirajlal Patel - Director
The latest financial statements of Aastha Oncology on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Aastha Oncology is 24AAGCA5597F1ZK, registered in Gujarat.
The CIN (Corporate Identification Number) of Aastha Oncology is U85110GJ2007PTC051327. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aastha Oncology was incorporated on 16 July 2007, making it 19+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Aastha Oncology has 4 deals on record (3 secondary share transfers, 1 funding round), with disclosed funding of ₹20 Lakh; the latest was in March 2019.
Rajendra Bhagwandas Toprani ceased to be Additional Director on 30 Sep 2008. Vijay Govinda Devanhalli ceased to be Additional Director on 30 Sep 2008. Rajendra Bhagwandas Toprani was appointed as Director on 17 Jul 2007. Aastha Oncology has 6 board changes on record in total.
Aastha Oncology can be reached through the website aasthacancer.org. Its registered office is in Ahmedabad, Gujarat, India.
The registered office of Aastha Oncology is at Hcg Aastha Cancer Centre CO. Hcg Medi Surge Hospitals Private Limited, Tp – 56 Fp – 82 Survey No – 1382 Opp. Sola Bhagvat Vidhyapith, Ahmedabad, Gujarat, India – 380060.

